| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS44026744 | HTLV-1 | ENSG00000273079.7 | protein_coding | GRIN2B | No | No | 2904 | Q13224 |
| TVIS44010098 | HTLV-1 | ENSG00000273079.7 | protein_coding | GRIN2B | No | No | 2904 | Q13224 |
| TVIS44020528 | HTLV-1 | ENSG00000273079.7 | protein_coding | GRIN2B | No | No | 2904 | Q13224 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | GRIN2B |
|---|---|
| DrugBank ID | DB11823 |
| Drug Name | Esketamine |
| Target ID | BE0000417 |
| UniProt ID | Q13224 |
| Regulation Type | antagonist |
| PubMed IDs | 29736744 |
| Citations | Molero P, Ramos-Quiroga JA, Martin-Santos R, Calvo-Sanchez E, Gutierrez-Rojas L, Meana JJ: Antidepressant Efficacy and Tolerability of Ketamine and Esketamine: A Critical Review. CNS Drugs. 2018 May;32(5):411-420. doi: 10.1007/s40263-018-0519-3. |
| Groups | Approved; Investigational |
| Direct Classification | Chlorobenzenes |
| SMILES | CN[C@@]1(CCCCC1=O)C1=CC=CC=C1Cl |
| Pathways | |
| PharmGKB | |
| ChEMBL | CHEMBL395091 |
